All news from Nuclear Medicine

Nuclear medicine

PET/CT in Suspected Salivary Gland Carcinoma

The study find that PET/CT -based diagnostic strategy adds decisive new information compare to conventional imaging in the evaluation of salivary gland tumours and the detection of cervical lymph node metastases; distant metastases; and synchronous cancer in patients with salivary gland carcinoma. Therefore Salivary gland carcinoma is an uncommon disease and represents only 3–5% of…

Nuclear medicine

PET/CT Ties Ischemia Risk to Artery Inflammation

The study find that PET/CT images are offering evidence of a link between vascular patterns at the time of diagnosis for giant cell arteritis and a patient’s risk of an ischemic event; therefore Spanish researchers explain in a study publish online on 12 May in the European Journal of Nuclear Medicine and Molecular Imaging. Because…

Nuclear medicine

Role of 18F-FLT PET/CT in Suspected Recurrent Lymphoma

The study find that PET/CT is extensively used in the assessment of patients with lymphoma; as Fluoro-18-deoxyglucose (FDG) is routinely employ to detect areas of active disease. Although FDG is a sensitive tracer; its distribution is not tumour-specific, since activated macrophages and other inflammatory cells may present increased glucose metabolism; and  is report in aseptic…

Nuclear medicine

Nanoparticles Show Potential for PET/MRI Bimodal Imaging

Study find that nanoparticles (NPs) using multi modal PET/MRI showed promising improvements in imaging capabilities. Using an MR Solutions; cryogen free, 3T scanner with a PET clip on the sequential images are find to be highly beneficial providing high spatial resolution, high sensitivity; high technical maturity with a low radiation dose. This pioneering agent highlights…

Nuclear medicine

Positron Emission Tomography/Computed Tomography was Positive.

Eighty-nine patients with newly diagnose; biopsyprove HL (World Health Organization, classic type) are retrospectively analyze. Because The patients are diagnose from January 2010 to March 2013 at six hospitals in Southwest China. Because Staging adhere to the guidelines from the NCCN and included PET/CT and a bone marrow biopsy. Therefore Eligibility criteria are as follows:…

Nuclear medicine

MILabs for Upgrades To Its Molecular Imaging Capabilities

MILabs VECT or system is an extremely user-friendly; therefore fully integrate multimodal imaging technology use for the development of new diagnostic solutions and therapies. With its latest adaptive preclinical platform; therefore MILabs has succeed at commercializing a scalable imaging platform; able to accommodate PET, SPECT, Optical, and CT imaging in a single system. New diagnostic…

Nuclear medicine

PET and MRI Scans To Assess Brain Health Treatment

Carmichael and colleagues will use Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) scans to assess brain health in study participants. Because And to being a treatment center for cancer; Therefore Mary Bird Perkins has unique expertise with imaging technologies that can also permit assessment of brain health. The imaging technologies Approximately 200 Bogalusa…

Nuclear medicine

Practical Clinical Applications of Cardiac FFR-CT Analysis

In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 31-42(12) ;Talal Alzahrani, MD, Ahmed Tashkandi, MD, Abdullah Sarkar, MD, Claudio Smuclovisky, MD, James P. Earls, MD and Andrew D. Choi, MD, from the Division of Cardiology, The George Washington University School of Medicine, Washington, DC, USA; Department of Medicine, University…

Nuclear medicine

Accuracy of 68Ga-PSMA PET/CT In Detecting Primary Prostate Cancers

Multiparametric magnetic resonance imaging (mpMRI) has gained an increasingly large role in the local assessment of prostate cancer; ranging from risk stratification prior to initial prostate biopsy to anatomic assessment of known cancers prior to definitive therapy. PSMA PET/CT has similarly gained an increasingly large role in the assessment of distant prostate cancer metastases, whether…

Nuclear medicine

Experience of 18F-rhPSMA-7 PET Imaging in High-Risk

BURLINGTON, Mass. & OXFORD, England (BUSINESS WIRE)- May 6, 2019- Blue Earth Diagnostics, a molecular imaging diagnostics company; today announced results from early clinical experience in Germany with positron emission tomography/computed tomography (PET/CT) imaging using a lead radiohybrid Prostate Specific Membrane Antigen-targeted compound ( 18 F-rhPSMA-7) by the Technical University of Munich (TUM) in two…

Nuclear medicine

Zero TE Skull MRI in Patients With Head Trauma

Zero TE (ZTE) skull magnetic resonance imaging (MRI) can be a possible option for clinical use in patients with skull lesions and may be helpful in managing radio sensitive trauma patients; according to a study to be present at the ARRS 2019 Annual Meeting, set for May 5-10 in Honolulu, HI. The study is conduct…

Nuclear medicine

Vitamin D3 and Lumisterol Against UVB Induced Damage

Researchers tested whether novel CYP11A1-derived vitamin D3- and lumisterol-hydroxyderivatives, including 1,25(OH)2D3, 20(OH)D3, 1,20(OH)2D3, 20,23(OH)2D3, 1,20,23(OH)3D3, lumisterol, 20(OH)L3, 22(OH)L3,  can protect against UVB-induced damage in human epidermal keratinocytes. Cells are treat with above compounds for 24 h, then subject to UVB irradiation at UVB doses of 25, 50, 75, or 200 mJ/cm2, and then examine for…